Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Breakthrough Company????? Endovasc ENDV -- Ignore unavailable to you. Want to Upgrade?

To: Dr David Summers who wrote (36)	4/18/1999 7:58:00 PM
From: Mack Carter	Respond to of 94

Where??? I could use a URL. M-A-C-K ;)

To: Dr David Summers who wrote (36)	4/19/1999 2:51:00 AM
From: Dorine Essey	Read Replies (1) \| Respond to of 94

Endovasc Ltd., Inc. Again Clarifies Rumors April 18, 1999 06:04 PM MONTGOMERY, Texas--(BW HealthWire)--April 18, 1999--Endovasc Ltd., Inc. ENDV today announced that its management has again been made aware of Internet rumors regarding a potential joint venture or buy-out with Glaxo-Wellcome, Inc. The management of Endovasc again state emphatically that " ... there is no confirmed nor pending transaction between our company and Glaxo-Wellcome. These are unsubstantiated and unfounded rumors." Endovasc Ltd., Inc. is a biopharmaceutical company using liposomal drug delivery for products that have already shown safety and efficacy in the generic form. The company's products and processes are covered by patents and trade secrets for competing in a $2 billion market. Please direct all inquiries to: PMR & Associates 1042 North El Camino Real, Suite No. B-266 Encinitas, CA 92024